2024-05-13 17:41:32 ET
More on Voyager Therapeutics
- Voyager Therapeutics: On Track To Deliver High Returns On Investment
- Voyager Therapeutics: A Tortoise With A Shot At Making Gene Therapy Deliver Easier
- Voyager Therapeutics, Inc. (VYGR) Q4 2023 Earnings Call Transcript
- Voyager Therapeutics GAAP EPS of -$0.20 beats by $0.24, revenue of $19.5M beats by $10.02M
- Voyager Therapeutics GAAP EPS of $1.25 beats by $1.54, revenue of $90.06M beats by $69.42M
Read the full article on Seeking Alpha
For further details see:
Voyager Therapeutics up 8% following quarterly beats